Moderna will continue to lead clinical development and manufacturing for mRNA-3927Moderna to receive up to $160 million in upfront and near-term development and regulatory milestones, in addition to ...
DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...
The global interventional radiology (IR) market is expected to expand at a compound annual growth rate (CAGR) of ...
Global AR and VR in Healthcare Market OverviewThe global Augmented Reality (AR) and Virtual Reality (VR) healthcare market is ...
The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast ...
FutureWise Research, a leading provider of healthcare market intelligence, today announced the release of its comprehensive report on the Metabolic Disorder Therapeutics Market, offering an in-depth ...
The global amniotic products market is projected to grow at a CAGR of approximately 8%, reaching nearly USD 1 billion by 2031 ...
February 3-5 at the Anaheim Convention Center, Anaheim, CA. BELLINGHAM, MASSACHUSETTS / ACCESS Newswire / January 29, 2026 / Medical Component Specialists (MCS) will be exhibited at booth #3277, ...
Collaboration will bring next generation orchestration and modular automation to scientists worldwide INDIANAPOLIS – (January 29, 2026) – Beckman Coulter Life Sciences and Automata today announced a ...
LOS ANGELES, CA / ACCESS Newswire / January 29, 2026 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable feedstock into nutraceuticals ...
Patients can access meds and labs in a single visit AUSTIN, TX / ACCESS Newswire / January 29, 2026 / BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company ...
Creating a scalable, AI‑native Virtual ICU platform that drives new recurring revenue and enterprise value. SAN JOSE, CALIFORNIA / ACCESS Newswire / January 29, 2026 / VSee Health, Inc. (Nasdaq:VSEE), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results